Pierluigi Porcu

6 days ago | ajmc.com | Kyle Munz |Pierluigi Porcu

As treatment advances continue to reshape chronic lymphocytic leukemia (CLL) care, clinicians face the growing challenge of aligning clinical efficacy with long-term cost sustainability, explained Pierluigi Porcu, MD, director, Division of Hematologic Malignancies, Jefferson Health. To strike this balance, he argued, will take a more holistic understanding of the patient factors and available resources that could impact their treatment.